Sio Capital Management »

Immunome shares owned by Sio Capital Management

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Sio Capital Management from 13F filings

Historical chart of Sio Capital Management investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Sio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Sio Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.6M 165k 21.87

More positions owned by Sio Capital Management

Maximus (MMS)
Waystar Holding Corp (WAY)
Icon SHS (ICLR)
AmerisourceBergen (COR)
Dianthus Therapeutics (DNTH)
Anteris Technologies Global (AVR)
Corcept Therapeutics Incorporated (CORT)
Livanova SHS (LIVN)
Tyra Biosciences (TYRA)
Celcuity (CELC)
GSK Sponsored Adr (GSK)
Biosante Pharmaceuticals (ANIP)
Abbott Laboratories (ABT)
Embecta Corp Common Stock (EMBC)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Sio Capital Management

Top funds holding Immunome

FMR
BlackRock
Redmile Group
State Street Corporation
PRIMECAP Management Company
Wellington Management Company
Vanguard Capital Management
Driehaus Capital Management
Enavate Sciences GP
Morgan Stanley
Geode Capital Management
Leucadia National Corporation
Silverarc Capital Management
Sofinnova Ventures
Woodline Partners

View all funds holding Immunome